Nuvation Bio, Inc. (NUVB)
6.81
+0.04
(+0.59%)
USD |
NYSE |
Sep 04, 16:00
6.82
+0.01
(+0.15%)
Pre-Market: 20:00
Nuvation Bio SG&A Expense (TTM) : 158.58M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 158.58M |
| March 31, 2026 | 154.48M |
| December 31, 2025 | 151.56M |
| September 30, 2025 | 137.37M |
| June 30, 2025 | 119.60M |
| March 31, 2025 | 97.27M |
| December 31, 2024 | 69.23M |
| September 30, 2024 | 48.58M |
| June 30, 2024 | 36.77M |
| March 31, 2024 | 28.16M |
| December 31, 2023 | 28.53M |
| September 30, 2023 | 30.52M |
| June 30, 2023 | 30.78M |
| Date | Value |
|---|---|
| March 31, 2023 | 32.19M |
| December 31, 2022 | 31.92M |
| September 30, 2022 | 32.06M |
| June 30, 2022 | 29.69M |
| March 31, 2022 | 27.14M |
| December 31, 2021 | 24.28M |
| September 30, 2021 | 21.11M |
| June 30, 2021 | 18.36M |
| March 31, 2021 | 13.63M |
| December 31, 2020 | 10.95M |
| September 30, 2020 | 6.516M |
| June 30, 2020 | 3.597M |
| March 31, 2020 | 1.925M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 7.413B |
| Johnson & Johnson | 25.14B |
| Pfizer Inc. | 13.72B |
| Eli Lilly & Co. | 12.24B |
| Merck & Co., Inc. | 11.14B |